The attention focused on ivermectin's potential usage for Covid-19 and cancer therapies highlights a critical point in the intersection of medical research and patient care. The pressing need for efficacious treatments amid a global health crisis and the continued struggle against cancer has thrust this drug into the limelight. Nonetheless, a detailed and moderated methodology rooted in rigorous scientific investigation is necessary moving forward. The existing evidence landscape, marked by divergent study findings and ongoing discussions, points towards the necessity for methodically planned, large-scale clinical trials to confirm ivermectin's effectiveness and safety in these new treatment scenarios.